The difference in miR-21 expression levels between invasive and non-invasive breast cancers emphasizes its role in breast cancer invasion

scientific article

The difference in miR-21 expression levels between invasive and non-invasive breast cancers emphasizes its role in breast cancer invasion is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S12032-014-0867-X
P8608Fatcat IDrelease_t3kod2tonvdudbyvj6fy72tdju
P698PubMed publication ID24488617
P5875ResearchGate publication ID260041149

P50authorLidija TodorovicQ86216137
Boban StanojevicQ48027092
Nina PetrovicQ58023844
Vesna MandusicQ59199703
P2093author name stringBogomir Dimitrijević
Jelena Roganović
Silvana Lukić
P2860cites workImportant increase of invasive lobular breast cancer incidence in Geneva, SwitzerlandQ73135577
High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1Q79643431
Overexpression of circulating miRNA-21 and miRNA-146a in plasma samples of breast cancer patientsQ95393010
MicroRNA gene expression deregulation in human breast cancerQ27860690
Novel human PDCD4 (H731) gene expressed in proliferative cells is expressed in the small duct epithelial cells of the breast as revealed by an anti-H731 antibodyQ28142514
Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cellsQ28256740
miR-21-mediated tumor growthQ29616149
microRNA, cell cycle, and human breast cancerQ33703585
MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expressionQ33784804
Presence of an in situ component is associated with reduced biological aggressiveness of size-matched invasive breast cancer.Q33834430
Expression profile of mammalian microRNAs in endometrioid adenocarcinomaQ34902744
Immunohistochemical detection of steroid receptors in breast cancer: a working protocol. UK Receptor Group, UK NEQAS, The Scottish Breast Cancer Pathology Group, and The Receptor and Biomarker Study Group of the EORTCQ35570987
Expression of tissue inhibitor of matrix metalloproteinases (TIMP)-3 protein in invasive breast carcinoma: relation to tumor phenotype and clinical outcomeQ35605873
Classification of ductal carcinoma in situ by gene expression profilingQ35605885
Prognostic Implications of MicroRNA-21 Overexpression in Invasive Ductal Carcinomas of the BreastQ35713817
The role of microRNAs in breast cancer migration, invasion and metastasisQ36396579
Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancerQ36546638
Genetic heterogeneity of breast cancer metastasis may be related to miR-21 regulation of TIMP-3 in translationQ37045230
Micromanagers of malignancy: role of microRNAs in regulating metastasisQ37233362
Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerationsQ37388937
MicroRNA function in cancer: oncogene or a tumor suppressor?Q37655612
Regulation and function of miRNA-21 in health and disease.Q37895431
MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1).Q38303663
Identification of miR-21 targets in breast cancer cells using a quantitative proteomic approachQ39878140
Membrane type 1 matrix metalloprotease cleaves laminin-10 and promotes prostate cancer cell migrationQ40407110
Tissue inhibitors of metalloproteinase expression in human breast cancer: TIMP-3 is associated with adjuvant endocrine therapy success.Q44850177
Epigenetics and microRNAsQ46057707
Clinical significance of miR-21 expression in breast cancer: SYBR-Green I-based real-time RT-PCR study of invasive ductal carcinoma.Q50603014
Preparation and characterization of recombinant tissue inhibitor of metalloproteinase 4 (TIMP-4).Q52553751
Genetic pathways in the evolution of breast ductal carcinoma in situQ57006156
P433issue3
P921main subjecttumor invasionQ60750433
P304page(s)867
P577publication date2014-02-02
P1433published inMedical OncologyQ2152666
P1476titleThe difference in miR-21 expression levels between invasive and non-invasive breast cancers emphasizes its role in breast cancer invasion
P478volume31

Reverse relations

cites work (P2860)
Q37022250Androgens downregulate miR-21 expression in breast cancer cells underlining the protective role of androgen receptor
Q48030886Changes in miR-221/222 Levels in Invasive and In Situ Carcinomas of the Breast: Differences in Association with Estrogen Receptor and TIMP3 Expression Levels
Q33820667Dehydroepiandrosterone-induces miR-21 transcription in HepG2 cells through estrogen receptor β and androgen receptor
Q38987650Expression and clinicopathological significance of microRNA-21 and programmed cell death 4 in malignant melanoma
Q64970233Expression of microRNA-3133 correlates with the prognosis in patients with clear cell renal cell carcinoma.
Q35247522Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker
Q54356219Higher miR-21 expression in invasive breast carcinomas is associated with positive estrogen and progesterone receptor status in patients from Serbia.
Q39377639Levels of MicroRNA Heterogeneity in Cancer Biology.
Q33364654MicroRNA in breast cancer: The association with BRCA1/2.
Q48146192MicroRNA-21 antisense oligonucleotide improves the sensitivity of A375 human melanoma cell to Cisplatin: An in vitro study
Q36089730MicroRNA‑21 regulates the expression of BTG2 in HepG2 liver cancer cells
Q60958994Non-Coding RNAs in Breast Cancer: Intracellular and Intercellular Communication
Q90183453Novel breast cancer screening: combined expression of miR-21 and MMP-1 in urinary exosomes detects 95% of breast cancer without metastasis
Q38849205Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis.
Q39581773Transcriptome Analysis of Cultured Limbal Epithelial Cells on an Intact Amniotic Membrane following Hypothermic Storage in Optisol-GS.
Q38739495miR-21 Might be Involved in Breast Cancer Promotion and Invasion Rather than in Initial Events of Breast Cancer Development.
Q35113386miRNA - Therapeutic tool in breast cancer? Where are we now?
Q57106025microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy
Q38336073microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer

Search more.